Dr. Becerra on Emerging Treatments in Pancreatic Cancer

Carlos Becerra, MD
Published: Thursday, Nov 16, 2017



Carlos Becerra, MD, physician, Texas Oncology, discusses emerging treatments for patients with pancreatic cancer.

Pancreatic cancer is one of the leading cancer-related deaths, states Beccera. There are currently no good treatment options, although progress has been made.

According to Beccera, newer chemotherapeutic agents and sequencing studies have helped to improve the field. Additionally, the new era of targeted therapy and immunotherapy will provide additional benefit that is needed for patients with metastatic pancreatic cancer.
 


Carlos Becerra, MD, physician, Texas Oncology, discusses emerging treatments for patients with pancreatic cancer.

Pancreatic cancer is one of the leading cancer-related deaths, states Beccera. There are currently no good treatment options, although progress has been made.

According to Beccera, newer chemotherapeutic agents and sequencing studies have helped to improve the field. Additionally, the new era of targeted therapy and immunotherapy will provide additional benefit that is needed for patients with metastatic pancreatic cancer.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and MyelomaApr 27, 20182.0
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell TumorsApr 28, 20181.0
Publication Bottom Border
Border Publication
x